Varicella zoster immune globulin (Cangene Corporation)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameVaricella zoster immune globulin (Cangene Corporation)
Drug Alias NameVarizig
ClassificationBiologics > Blood componentsBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsVaricella Zoster Virus Infection
Global Approved IndicationsVaricella Zoster Virus Infection
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2012/12/20
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCangene Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsVaricella Zoster Virus Infection
Inactive IndicationsN/A

Other Information

ATC CodeJ06BB03
Related LinksN/A